Dae Ho Lee - Institute for Innovative Cancer Research, University of Ulsan

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 452 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

BLU-945, a Potent and Selective Next-Generation EGFR TKI, Has Antitumor Activity in Models of Osimertinib-Resistant Non-Small-cell Lung Cancer

Sun Min Lim,Stefanie S Schalm,Eun Ji Lee,Sewon Park,Chiara Conti, Yves A Millet,Rich Woessner,Zhuo Zhang, Luz E Tavera-Mendoza, Faith Stevison,Faris Albayya, Thomas A Dineen, John Hsieh, Seung Yeon Oh,Alena Zalutskaya,Julia Rotow,Koichi Goto,Dae-Ho Lee,Mi Ran Yun,Byoung Chul Cho

Therapeutic advances in medical oncology (2024): 17588359241280689-17588359241280689

引用0浏览0WOS引用

Abstract 4998: Pralsetinib Induces Opportunistic Infection in RET Fusion-Positive NSCLC Patients Via Inhibition of IL-2 Production by Blocking Jak3-Stat5 Activation

Shinkyo Yoon,Hyun-Min Ryu,Sang-We Kim,Kang-Seo Park,Dae Ho Lee

Cancer Researchno. 6_Supplement (2024): 4998-4998

引用0浏览0引用

Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

Inha Jung,Seungyoon Nam, Soyoung Park,Da Young Lee,Ji Hee Yu,Ji A. Seo,Dae Ho Lee,Nan Hee Kim

DIABETES (2024)

引用0浏览0WOS引用

Diagnostic Accuracy of Non-Invasive Tests to Screen for At-Risk MASH-An Individual Participant Data Meta-Analysis

LIVER INTERNATIONALno. 8 (2024): 1872-1885

引用0浏览0WOS引用

Krascendo-170 Lung: A Phase Ib/II Study of Divarasib + Pembrolizumab ± Platinum-Based Chemotherapy and Pemetrexed in Untreated KRAS G12C+advanced Non-Small Cell Lung Cancer (NSCLC)

Ferdinandos Skoulidis,Kristof Cuppens,Adrian G. Sacher, Vamsidhar Velcheti,Dae Ho Lee,Mark T. Lin,Tharu M. Fernando,Shuai Li,Denise Bradley, Martina Zarak Crnkovic,Michael Mathisen

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Avelumab Versus Platinum-Based Doublet Chemotherapy As First-Line Treatment for Patients with High-Expression Programmed Death-Ligand 1–positive Metastatic NSCLC: Primary Analysis from the Phase 3 JAVELIN Lung 100 Trial

Martin Reck,Fabrice Barlesi,James Chih-Hsin Yang,Virginie Westeel,Enriqueta Felip,Mustafa Ozguroglu,Manuel Cobo Dols, Richard Sullivan,Dariusz M. Kowalski,Zoran Andric,Dae Ho Lee,Ahmet Sezer, Ping Hu,XiaoZhe Wang,Anja von Heydebreck, Natalia Jacob,Keyvan Tadjalli Mehr,Keunchil Park

JOURNAL OF THORACIC ONCOLOGYno. 2 (2024): 297-313

引用0浏览0WOS引用

Makoto Nishio,Yi-Long Wu,Fabrice Barlesi,Jin Seok Ahn,Dae Ho Lee, Jong-Seok Lee,Wenzhao Zhong,Hidehito Horinouchi,Maximilian Hochmair,Hiroshi Tanaka,Maciej Glogowski,Achim Rittmeyer,Mary J. Fidler,Anna Wrona, Carla Mamolo,Andres Cardona,Thorsten Ruf,Vlatka Smoljanovic,Benjamin J. Solomon

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Capmatinib Plus Nazartinib in Patients with EGFR-Mutated Non–Small Cell Lung Cancer

Enriqueta Felip,Giulio Metro,Ross A. Soo,Jürgen Wolf,Benjamin J. Solomon,Daniel SW Tan,Andrea Ardizzoni,Dae Ho Lee,Lecia V. Sequist,Fabrice Barlesi,Santiago Ponce-Aix,Delvys Rodriguez Abreu,Maria Rosario Garcia Campelo,Mette Sprauten, Leslie O’Sullivan Djentuh,Nathalie Smith, Aline Jary,Riccardo Belli,Sabine Glaser,Mike Zou

European journal of cancerpp.114182-114182, (2024)

引用0浏览0WOS引用

GR113808, a Serotonin Receptor 4 Antagonist, Prevents High-Fat-diet-induced Obesity, Fatty Liver Formation, and Insulin Resistance in C57BL/6J Mice

Min Hee Kim,Su-Jeong Kim, Woo-Jae Park,Dae Ho Lee, Kyoung-Kon Kim

BMC pharmacology & toxicologyno. 1 (2024): 76-76

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn